Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

63 results about "Endovascular therapy" patented technology

Device and method for endovascular treatment for causing closure of a blood vessel

An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications. In yet another aspect of the present invention, a spacer comprises an inner sleeve and an outer sleeve both arranged around a distal portion of the core to prevent the laser light from traveling laterally and to position the light emitting face away from an inner wall of the vessel. The inner sleeve can be a heat resistive material such as ceramic and the outer sleeve can be, for example, a metallic sleeve to provide structural integrity and strength to the distal section of the treatment device.
Owner:ANGIODYNAMICS INC

Stent distracting vena cava membrane breaker

The invention discloses a stent distracting vena cava membrane breaker applied to endovascular therapy. In an interventional therapy membrane Budd-Chiari syndrome method used in recent years, a hollow puncture needle is used, and the principle is: breaking a membrane with the puncture needle, making a guide wire pass through the membrane, and guiding a saccule to expand for eliminating a narrow section, or directly breaking the membrane with the guide wire. The key point of the technology is that: a needle head is aligned with the center of the membrane with appropriate force. The defect is that: if the needle head is not aligned with the center but is deviated towards the periphery, and excessive force is applied, blood vessels are broken, and hydropneumothorax or cardiac tamponade which endangers the life of a patient is caused by wrong insertion of the needle head into a pleura or a pericardium. The invention provides a stent which can contract and expand is arranged on the head part of a puncture needle sheath catheter on the basis of the conventional puncture needle, and stronger support force and more accurate directional property are provided for a membrane breaking needle under the coaction of the unfolded stent and a blood vessel cavity. By adopting the stent distracting vena cava membrane breaker, the defects of the prior art can be overcome, and a good membrane breaking effect is achieved.
Owner:SUZHOU INNOMED MEDICAL DEVICE

Saccule-type vena cava membrane puncturing dilator

InactiveCN102302378AEffective control directionControl directionSurgeryDilatorsSacculeDilator
The invention discloses a vena cava membrane puncturing device used for endovascular therapy. In recent years, the method for interventional therapy of the membrane-type Budd-Chiari syndrome (BCS) utilizes a hollow membrane puncturing needle and adopts the principle that a membrane is punctured by the membrane puncturing needle, a guide wire penetrates through the membrane to guide a saccule to dilate so as to eliminate a stenotic segment, or the membrane is directly punctured by the guide wire. The technology has the key point that the needle head is aligned to the center of the membrane and proper force is required, while the defect lies in that if the direction of the needle head does not align to the center but deviate to the periphery and the force is overlarge, a blood vessel can be punctured, the membrane puncturing needle is mistakenly punctured into the pleura or the heart sac, causing unnecessary injury, and a saccule catheter is required to be changed for secondary membrane dilatation after the membrane puncturing. The invention provides a vena cava membrane puncturing dilator, which is characterized in that a dilatable saccule with fixing and orienting functions is added on the periphery of the tip of traditional membrane puncturing needle, and can overcome the defects of high difficulty of the membrane puncturing technology and high risk and achieve better effects of one-time membrane puncturing and membrane dilatation.
Owner:曲乐丰 +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products